ELDN — Eledon Pharmaceuticals Inc

Ownership history in Siren, L.L.C.  ·  3 quarters on record

This page tracks every 13F SEC filing in which Siren, L.L.C. reported a position in Eledon Pharmaceuticals Inc (ELDN). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.21% (2025 Q3)
Avg. % of fund
0.15%
First filed
2025 Q1
Last filed
2025 Q3
Quarters held
3
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 ADDED 2,072,767 +1,382,597 +200.3% 0.21% $5.4M $2.59
2025 Q2 UNCHANGED 690,170 — 0% 0.10% $1.9M $2.71
2025 Q1 INITIATED 690,170 — — 0.13% $2.3M $3.39
% of Fund (quarterly)    ELDN price (monthly, adj. close)

Other funds also holding ELDN

As of 2025 Q4 — sorted by position size

Stonepine Capital Management, LLC 3Y 7Y 0.98% CM Management, LLC 3Y 0.83% SPHERA FUNDS MANAGEMENT LTD. 3Y 7Y 0.62% 22NW, LP 3Y 7Y 0.4% Catalio Capital Management, LP 0.34% BVF INC/IL 3Y 7Y 0.32% Blue Owl Capital Holdings LP 3Y 0.22% ADAR1 Capital Management, LLC 0.2% KINGDON CAPITAL MANAGEMENT, L.L.C. 3Y 7Y 0.19% AWM Investment Company, Inc. 3Y 7Y 0.16%
← Back to Siren, L.L.C. Holdings